Lawrence Eichenfield's most recent trade in Verrica Pharmaceuticals Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Forte Biosciences Inc | Lawrence Eichenfield | Director | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | ||
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
Forte Biosciences Inc | Lawrence Eichenfield | Director | 01 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
Forte Biosciences Inc | Lawrence Eichenfield | Director | 23 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 8,109 | 8,109 | - | - | Stock Option (right to buy) | |
Forte Biosciences Inc | Lawrence Eichenfield | Director | 28 May 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | ||
Verrica Pharmaceuticals Inc | Lawrence Eichenfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 17,502 | 17,502 | - | - | Stock Option (right to buy) |